We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Predictive Value of 18F-FAZA in Rectum Cancer (FAZA)

This study has been terminated.
(The logistics of this trial (incl. supply of tracer) in connection with the patients' treatment course caused the inclusion rate to be very slow.)
Sponsor:
ClinicalTrials.gov Identifier:
NCT01257035
First Posted: December 9, 2010
Last Update Posted: June 17, 2013
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Aarhus University Hospital
Information provided by (Responsible Party):
Vejle Hospital
  Purpose
The primary purpose of the study is to investigate 18F-FAZA-PETs role as predictor of response to neoadjuvant chemoradiation of locally advanced rectum cancer.

Condition Intervention
Locally Advanced Rectum Cancer Other: 18F-FAZA-PET/CT

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: The Predictive Value of 18F-FAZA-PET/CT in Neoadjuvant Radiation for Patients With Locally Advanced Rectum Cancer

Further study details as provided by Vejle Hospital:

Primary Outcome Measures:
  • Response to chemoradiotherapy measured by TRG [ Time Frame: 8 weeks after chemoradiation treatment ]

Secondary Outcome Measures:
  • Recurrence free survival [ Time Frame: From date of inclusion till date of verified recurrence ]
  • Survival [ Time Frame: From date of inclusion till date of death by any cause ]

Enrollment: 21
Study Start Date: November 2010
Study Completion Date: August 2012
Primary Completion Date: February 2012 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
18F-FAZA-PET/CT Other: 18F-FAZA-PET/CT
Contrast fluid injected prior to scan

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Patients with locally advanced rectum cancer receiving preoperative radiation treatment and concomitant chemotherapy at the Dept. of Oncology, Vejle Hospital.
Criteria

Inclusion Criteria:

  • Histopatologically verified adenocarcinoma in the rectum
  • T4 tumor eller T3 tumor < 10 cm from the anus and < 5 mm from the mesorectal fascie measured by MR scan. At the distal part of the rectum the distance to the mesorectal fascie is < 5 mm and therefore all T3 tumors are included in this area
  • Suitable for preoperative radiation and chemotherapy
  • No distant metastases
  • Age >18 years
  • Hematology ANC ≥1.5x10^9/l. Thrombocytes ≥ 100x10^9/l.
  • Biochemistry Bilirubin ≤ 3 x UNL. ALAT ≤ 5 x UNL
  • Creatinine ≤ UNL
  • Contraception for fertile women
  • Written and orally informed consent

Exclusion Criteria:

  • Other malignant disease within 5 years, excl. non-melanotic skin cancer
  • Previous radiation treatment of the pelvis
  • Pregnant or breastfeeding women
  • Surgery within 6 weeks prior to enrollment
  • Serious concurrent medical disease
  • Enrollment in study "A prospective observational study of patients with rectum cancer after concomitant radiation and chemotherapy", where the patients are potientially not operated.
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01257035


Locations
Denmark
Vejle Hospital
Vejle, Denmark
Sponsors and Collaborators
Vejle Hospital
Aarhus University Hospital
  More Information

Responsible Party: Vejle Hospital
ClinicalTrials.gov Identifier: NCT01257035     History of Changes
Other Study ID Numbers: S-20100054
First Submitted: December 8, 2010
First Posted: December 9, 2010
Last Update Posted: June 17, 2013
Last Verified: June 2013

Keywords provided by Vejle Hospital:
Rectum cancer
FAZA
18F-FAZA-PET/CT
Radiotherapy
Chemoradiotherapy

Additional relevant MeSH terms:
Rectal Neoplasms
Colorectal Neoplasms
Intestinal Neoplasms
Gastrointestinal Neoplasms
Digestive System Neoplasms
Neoplasms by Site
Neoplasms
Digestive System Diseases
Gastrointestinal Diseases
Intestinal Diseases
Rectal Diseases